An Act Regarding the Prescribing and Dispensing of Naloxone Hydrochloride by Pharmacists
Sec. 1. 22 MRSA §2353, sub-§1, ¶D, as enacted by PL 2015, c. 508, §1, is amended to read:
Sec. 2. 22 MRSA §2353, sub-§2, ¶A-1, as enacted by PL 2015, c. 508, §2, is amended to read:
Sec. 3. 22 MRSA §2353, sub-§2, ¶A-2, as enacted by PL 2017, c. 249, §1, is repealed.
Sec. 4. 22 MRSA §2353, sub-§2, ¶C-1, as enacted by PL 2015, c. 508, §2, is amended to read:
Sec. 5. 22 MRSA §2353, sub-§2, ¶C-2, as enacted by PL 2017, c. 249, §1, is repealed.
Sec. 6. 32 MRSA §13815, sub-§1, as enacted by PL 2017, c. 249, §2, is repealed.
Sec. 7. 32 MRSA §13815, sub-§2, as enacted by PL 2017, c. 249, §2, is amended to read:
This subsection is repealed July 1, 2019.
Sec. 8. Maine Revised Statutes headnote amended; revision clause. In the Maine Revised Statutes, Title 32, chapter 117, subchapter 11-A, in the subchapter headnote, the words "dispensing of naloxone hydrochloride" are amended to read "prescribing and dispensing of naloxone hydrochloride" and the Revisor of Statutes shall implement this revision when updating, publishing or republishing the statutes.